| Active substance | plozasiran |
| Holder | Arrowhead Pharmaceuticals, Inc. |
| Status | Running |
| Indication | Familial Chylomicronemia Syndrome (FSC) |
| Public documents | Approbation |
| Information for the patient | |
| Informed consent | |
| Last update | 23/04/2025 |
plozasiran
Last updated on